Related references
Note: Only part of the references are listed.Relation of Neutrophil/Lymphocyte Ratio to Coronary Flow to In-Hospital Major Adverse Cardiac Events in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention
Mahmut Akpek et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Hematologic Parameters and Angiographic Progression of Coronary Atherosclerosis
Nihat Kalay et al.
ANGIOLOGY (2012)
Circulating immune complexes correlate with collagen carboxypropeptide in patients with essential hypertension
Caie Wu et al.
BLOOD PRESSURE (2012)
Inflammation, Immunity, and Hypertension
David G. Harrison et al.
HYPERTENSION (2011)
Prognostic value of plasma high-sensitivity C-reactive protein levels in Japanese patients with stable coronary artery disease: The Japan NCVC-Collaborative Inflammation Cohort (JNIC) Study
Yukihiko Momiyama et al.
ATHEROSCLEROSIS (2009)
Avaliação da relação neutrófilos/linfócitos em pacientes com suspeita de síndrome coronariana aguda
Ana Denise Zazula et al.
Arquivos Brasileiros de Cardiologia (2008)
Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease
Angela Papa et al.
CLINICA CHIMICA ACTA (2008)
The role of von Willebrand factor in thrombus formation
Zaverio M. Ruggeri
THROMBOSIS RESEARCH (2007)
Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension
S Manabe et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Which white blood cell subtypes predict increased cardiovascular risk?
BD Horne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Association of C-reactive protein with blood pressure and hypertension - Life course confounding and Mendelian randomization tests of causality
GD Smith et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Counts of neutrophils, lymphocytes, and monocytes, cause-specific mortality and coronary heart disease: The NHANES-1 epidemiologic follow-up study
RF Gillum et al.
ANNALS OF EPIDEMIOLOGY (2005)
Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients
R Marfella et al.
AMERICAN JOURNAL OF HYPERTENSION (2005)
Antihypertensive therapy and endothelial function
S Nadar et al.
CURRENT PHARMACEUTICAL DESIGN (2004)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence
LE Bautista
JOURNAL OF HUMAN HYPERTENSION (2003)
C-reactive protein and cardiovascular disease: new insights from an old molecule
GM Hirschfield et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2003)
Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes - A TACTICS-TIMI 18 substudy
MS Sabatine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis
S Navalkar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Preserving renal function in adults with hypertension and diabetes: A consensus approach
GL Bakris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)